Intranasal Delivery of Gene-Edited Microglial Exosomes Improves Neurological Outcomes after Intracerebral Hemorrhage by Regulating Neuroinflammation

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Neural inflammatory response is a crucial pathological change in intracerebral hemorrhage (ICH) which accelerates the formation of perihematomal edema and aggravates neural cell death. Although surgical and drug treatments for ICH have advanced rapidly in recent years, therapeutic strategies that target and control neuroinflammation are still limited. Exosomes are important carriers for information transfer among cells. They have also been regarded as a promising therapeutic tool in translational medicine, with low immunogenicity, high penetration through the blood-brain barrier, and ease of modification. In our previous research, we have found that exogenous administration of miRNA-124-overexpressed microglial exosomes (Exo-124) are effective in improving post-injury cognitive impairment. From this, we evaluated the potential therapeutic effects of miRNA-124-enriched microglial exosomes on the ICH mice in the present study. We found that the gene-edited exosomes could attenuate neuro-deficits and brain edema, improve blood–brain barrier integrity, and reduce neural cell death. Moreover, the protective effect of Exo-124 was abolished in mice depleted of Gr-1+ myeloid cells. It suggested that the exosomes exerted their functions by limiting the infiltration of leukocyte into the brain, thus controlling neuroinflammation following the onset of ICH. In conclusion, our findings provided a promising therapeutic strategy for improving neuroinflammation in ICH. It also opens a new avenue for intranasal delivery of exosome therapy using miRNA-edited microglial exosomes.
Funding Information
  • Haihe Laboratory of Cell Ecosystem Innovation Fund (22HHXBSS00047, 82072166, 82071394, 82102318, 20YFZCSY00030, TJWJ2021QN005)
  • National Natural Science Foundation of China (22HHXBSS00047, 82072166, 82071394, 82102318, 20YFZCSY00030, TJWJ2021QN005)
  • Tianjin Municipal Science and Technology Program (22HHXBSS00047, 82072166, 82071394, 82102318, 20YFZCSY00030, TJWJ2021QN005)
  • Science and Technology Project of Tianjin Municipal Health Commission (22HHXBSS00047, 82072166, 82071394, 82102318, 20YFZCSY00030, TJWJ2021QN005)

This publication has 57 references indexed in Scilit: